ID: ALA3601785

Max Phase: Preclinical

Molecular Formula: C17H20BrN7O3

Molecular Weight: 450.30

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cn1cnc(C[C@H](NC(=O)c2cnccn2)C(=O)N2CCC[C@H]2C(N)=O)c1Br

Standard InChI:  InChI=1S/C17H20BrN7O3/c1-24-9-22-10(14(24)18)7-11(23-16(27)12-8-20-4-5-21-12)17(28)25-6-2-3-13(25)15(19)26/h4-5,8-9,11,13H,2-3,6-7H2,1H3,(H2,19,26)(H,23,27)/t11-,13-/m0/s1

Standard InChI Key:  JZEDEIDXZNCULP-AAEUAGOBSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 450.30

Molecular Weight (Monoisotopic): 449.0811

AlogP: -0.21

#Rotatable Bonds: 6

Polar Surface Area: 136.10

Molecular Species: NEUTRAL

HBA: 7

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 10

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 13.54

CX Basic pKa: 5.09

CX LogP: -1.77

CX LogD: -1.77

Aromatic Rings: 2

Heavy Atoms: 28

QED Weighted: 0.63

Np Likeness Score: -0.90

References

1. Meena CL, Thakur A, Nandekar PP, Sangamwar AT, Sharma SS, Jain R..  (2015)  Synthesis of CNS active thyrotropin-releasing hormone (TRH)-like peptides: Biological evaluation and effect on cognitive impairment induced by cerebral ischemia in mice.,  23  (17): [PMID:26216015] [10.1016/j.bmc.2015.07.022]

Source

Source(1):

• Scientific Literature